About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
European Research Initiative on CLL - ERIC
http://www.ericll.org/
ERIC 2022
ERIC 2020
Workshop on IG Analysis in CLL
Videos
Event
ERIC Workshop on MRD Analysis in CLL
Videos
Event
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
2020 Updates on BCL-2 in R/R CLL: Can Navitoclax Prolong PFS? Does Venetoclax Help Reduce Disease Burden?
By
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
FEATURING
John Seymour
By
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
FEATURING
John Seymour
114 views
December 17, 2020
Recorded by OpenAudience™.
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
ERIC 2020
72:55
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
Expert Discussion on Frontline CLL: Is There Still a Role for Chemoi…
Feat.
J. Woyach,
J. Seymour,
K. Fischer,
F. Cymbalista,
G. Follows,
M. Hallek,
A. Tedeschi,
M. Davids,
W. Wierda
75:59
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
Expert Discussion on R/R CLL: Can We Continue Monotherapy After 2 yr…
Feat.
M. Van Gelder,
J. Brown,
A. Kater,
A. Cuneo,
P. Hillmen,
B. Eichhorst,
S. Schuster
14:36
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on CLL: How to Measure Proliferation by Heavy Water Lab…
Feat.
J. Burger
14:36
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on CLL: Does IL4I1 Promote Disease Development? Can We …
Feat.
M. Seiffert
13:24
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on CLL: Does Activation of Toll-Like Receptors Correlat…
Feat.
A. Wiestner
14:29
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on BCL-2 in R/R CLL: Can Navitoclax Prolong PFS? Does V…
Feat.
J. Seymour
17:39
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on Cell-Extrinsic Drivers in CLL: Do Microenvironmental…
Feat.
D. Efremov
16:43
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on Cell-Intrinsic Drivers in CLL: Does Ibrutinib Prolon…
Feat.
S. Stilgenbauer
13:05
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Highlights on Richter Syndrome in CLL: Clonally Related vs. Unr…
Feat.
D. Rossi
17:47
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Highlights on CLL: What Does NGS Result With in CLL? How Does I…
Feat.
C. Wu
13:54
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on CLL: Analysis of Spontaneous Regression - Proliferat…
Feat.
T. Stankovic
12:45
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on CLL: Diagnostic Considerations, Comparison With MCL,…
Feat.
A. Rawstron
14:38
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Updates on CLL: How to Define MBL and What Are the Features Rel…
Feat.
L. Scarfò
33:24
ERIC 2020 Virtual Meeting: New Frontiers in CLL Research
2020 Highlights on CLL: Genomic Changes, Dominance of IGHV1-69, Natu…
Feat.
F. Stevenson
